Cosmax 評価
A192820 は、フェアバリュー、アナリスト予測、市場との相対価格と比較して過小評価されているか？
評価スコア
3/6評価スコア 3/6
公正価値以下
公正価値を大幅に下回る
Price-To-Earnings vs ピア
Price-To-Earnings vs 業界
Price-To-Earnings対 公正比率
アナリスト予測
株価と公正価値の比較
A192820 、その将来キャッシュフローを見たときの公正価格はいくらになるだろうか？この見積もりには、割引キャッシュフローモデルを使用します。
公正価値以下: A192820 (₩155300) is trading below our estimate of fair value (₩315470.24)
公正価値を大幅に下回る: A192820 is trading below fair value by more than 20%.
主な評価指標
A192820 の相対評価を見る場合、どの指標を使うのがベストか？
相対評価に役立つその他の財務指標。
| A192820 のn/a レシオは？ | |
|---|---|
| 該当なし | 0x |
| n/a | n/a |
| 時価総額 | ₩1.76t |
| 主要統計 | |
|---|---|
| 企業価値／収益 | 1.1x |
| 企業価値／EBITDA | 10.6x |
| PEGレシオ | 0.9x |
株価収益率 同業他社との比較
A192820 のPE 比率は同業他社と比較してどうか。
Price-To-Earnings vs ピア: A192820 is expensive based on its Price-To-Earnings Ratio (24.2x) compared to the peer average (18.7x).
株価収益率 比率対業界
A192820'のPE レシオは、KR Personal Products 業界の他社と比較してどうか。
株価収益率 レシオ vs フェア・レシオ
A192820 のPE レシオは、同社の レシオと比較してどの程度か。 FairPE Ratio? これは、会社の予想利益成長率、利益率、その他のリスク要因を考慮した予想PE レシオです。
| 適正比率 | |
|---|---|
| 現在PE 比率 | 24.2x |
| 公正PE 比率 | 20.4x |
Price-To-Earnings対 公正比率: A192820 is expensive based on its Price-To-Earnings Ratio (24.2x) compared to the estimated Fair Price-To-Earnings Ratio (20.4x).
アナリストの目標株価
アナリストの12ヶ月の予想と、コンセンサス目標株価に対する統計的信頼性は？
| 日付 | 株価 | 1年間の平均目標株価 | 分散 | 高い | 低い | 1Y 実勢価格 | アナリスト |
|---|---|---|---|---|---|---|---|
| 現在 | ₩155,300.00 | ₩187,222.22 +20.6% | 10.9% | ₩239,000.00 | ₩160,000.00 | n/a | 18 |
| Oct ’25 | ₩146,000.00 | ₩187,176.47 +28.2% | 11.2% | ₩239,000.00 | ₩160,000.00 | n/a | 17 |
| Sep ’25 | ₩121,300.00 | ₩187,625.00 +54.7% | 11.5% | ₩239,000.00 | ₩160,000.00 | n/a | 16 |
| Aug ’25 | ₩154,000.00 | ₩213,000.00 +38.3% | 11.9% | ₩250,000.00 | ₩165,000.00 | n/a | 16 |
| Jul ’25 | ₩189,100.00 | ₩198,000.00 +4.7% | 9.3% | ₩239,000.00 | ₩165,000.00 | n/a | 16 |
| Jun ’25 | ₩170,000.00 | ₩194,812.50 +14.6% | 8.4% | ₩223,000.00 | ₩165,000.00 | n/a | 16 |
| May ’25 | ₩140,100.00 | ₩173,625.00 +23.9% | 11.4% | ₩223,000.00 | ₩124,000.00 | n/a | 16 |
| Apr ’25 | ₩130,000.00 | ₩164,937.50 +26.9% | 9.1% | ₩180,000.00 | ₩124,000.00 | n/a | 16 |
| Mar ’25 | ₩107,600.00 | ₩173,250.00 +61.0% | 7.2% | ₩200,000.00 | ₩145,000.00 | n/a | 16 |
| Feb ’25 | ₩113,700.00 | ₩173,250.00 +52.4% | 7.2% | ₩200,000.00 | ₩145,000.00 | n/a | 16 |
| Jan ’25 | ₩126,400.00 | ₩172,062.50 +36.1% | 7.2% | ₩200,000.00 | ₩145,000.00 | n/a | 16 |
| Dec ’24 | ₩112,100.00 | ₩164,058.82 +46.4% | 15.1% | ₩200,000.00 | ₩100,000.00 | n/a | 17 |
| Nov ’24 | ₩133,600.00 | ₩163,533.33 +22.4% | 15.7% | ₩200,000.00 | ₩100,000.00 | ₩153,200.00 | 15 |
| Oct ’24 | ₩128,700.00 | ₩158,928.57 +23.5% | 16.7% | ₩192,000.00 | ₩100,000.00 | ₩146,000.00 | 14 |
| Sep ’24 | ₩151,800.00 | ₩157,500.00 +3.8% | 16.4% | ₩192,000.00 | ₩100,000.00 | ₩121,300.00 | 14 |
| Aug ’24 | ₩101,900.00 | ₩118,714.29 +16.5% | 10.7% | ₩141,000.00 | ₩100,000.00 | ₩154,000.00 | 14 |
| Jul ’24 | ₩93,000.00 | ₩109,214.29 +17.4% | 12.7% | ₩130,000.00 | ₩70,000.00 | ₩189,100.00 | 14 |
| Jun ’24 | ₩81,100.00 | ₩108,142.86 +33.3% | 12.1% | ₩130,000.00 | ₩70,000.00 | ₩170,000.00 | 14 |
| May ’24 | ₩77,200.00 | ₩99,916.67 +29.4% | 11.7% | ₩115,000.00 | ₩70,000.00 | ₩140,100.00 | 12 |
| Apr ’24 | ₩81,000.00 | ₩99,500.00 +22.8% | 11.8% | ₩115,000.00 | ₩70,000.00 | ₩130,000.00 | 12 |
| Mar ’24 | ₩77,300.00 | ₩87,923.08 +13.7% | 16.0% | ₩115,000.00 | ₩65,000.00 | ₩107,600.00 | 13 |
| Feb ’24 | ₩78,400.00 | ₩88,428.57 +12.8% | 14.9% | ₩107,000.00 | ₩65,000.00 | ₩113,700.00 | 14 |
| Jan ’24 | ₩74,100.00 | ₩76,461.54 +3.2% | 14.6% | ₩103,000.00 | ₩65,000.00 | ₩126,400.00 | 13 |
| Dec ’23 | ₩63,300.00 | ₩77,428.57 +22.3% | 16.9% | ₩103,000.00 | ₩60,000.00 | ₩112,100.00 | 14 |
| Nov ’23 | ₩47,800.00 | ₩81,571.43 +70.7% | 19.6% | ₩103,000.00 | ₩60,000.00 | ₩133,600.00 | 14 |
アナリスト予測: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.